Kinetics and Mechanism of Oxidation of 2-Mercaptoethanol by the Heteropolyoxovanadate [MnV13O38]7−

Catalytic System for Aerobic Oxidation That Simultaneously Functions as Its Own Redox Buffer

The control of the solution electrochemical potential as well as pH impacts products in redox reactions, but the former gets far less attention. Redox buffers facilitate the maintenance of potentials and have been noted in diverse cases, but they have not been a component of catalytic systems. We report a catalytic system that contains its own built-in redox buffer. Two highly synergistic components (a) the tetrabutylammonium salt of hexavanadopolymolybdate TBA₄H₅[PMo₆V₆O₄₀] (PV₆Mo₆) and (b) Cu(ClO₄)₂ in acetonitrile catalyze the aerobic oxidative deodorization of thiols by conversion to the corresponding nonodorous disulfides at 23 °C (each catalyst alone is far less active). For example, the reaction of 2-mercaptoethanol with ambient air gives a turnover number (TON) = 3 × 10² in less than one hour with a turnover frequency (TOF) of 6 × 10^-2 s^-1 with respect to PV₆Mo₆. Multiple electrochemical, spectroscopic, and other methods establish that (1) PV₆Mo₆, a multistep and multielectron redox buffering catalyst, controls the speciation and the ratio of Cu(II)/Cu(I) complexes and thus keeps the solution potential in different narrow ranges by involving multiple POM redox couples and simultaneously functions as an oxidation catalyst that receives electrons from the substrate; (2) Cu catalyzes two processes simultaneously, oxidation of the RSH by PV₆Mo₆ and reoxidation of reduced PV₆Mo₆ by O₂; and (3) the analogous polytungstate-based system, TBA₄H₅[PW₆V₆O₄₀] (PV₆W₆), has nearly identical cyclic voltammograms (CV) as PV₆Mo₆ but has almost no catalytic activity: it does not exhibit self-redox buffering.

Decavanadate Toxicology and Pharmacological Activities: V10 or V1, Both or None?

This review covers recent advances in the understanding of decavanadate toxicology and pharmacological applications. Toxicological in vivo studies point out that V10 induces several changes in several oxidative stress parameters, different from the ones observed for vanadate (V1). In in vitro studies with mitochondria, a particularly potent V10 effect, in comparison with V1, was observed in the mitochondrial depolarization (IC50 = 40 nM) and oxygen consumption (99 nM). It is suggested that mitochondrial membrane depolarization is a key event in decavanadate induction of necrotic cardiomyocytes death. Furthermore, only decavanadate species and not V1 potently inhibited myosin ATPase activity stimulated by actin (IC50 = 0.75 μM) whereas exhibiting lower inhibition activities for Ca(2+)-ATPase activity (15 μM) and actin polymerization (17 μM). Because both calcium pump and actin decavanadate interactions lead to its stabilization, it is likely that V10 interacts at specific locations with these proteins that protect against hydrolysis but, on the other hand, it may induce V10 reduction to oxidovanadium(IV). Putting it all together, it is suggested that the pharmacological applications of V10 species and compounds whose mechanism of action is still to be clarified might involve besides V10 and V1 also vanadium(IV) species.